Published in J Gen Microbiol on October 01, 1986
Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3. Antimicrob Agents Chemother (1988) 2.28
Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother (2002) 2.11
Genetic and phenotypic diversity among ampicillin-resistant, non-beta-lactamase-producing, nontypeable Haemophilus influenzae isolates. Infect Immun (1987) 1.86
Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev (2007) 1.74
Resistance of clinical isolates of Haemophilus influenzae in United Kingdom 1986. Br Med J (Clin Res Ed) (1987) 1.65
Molecular basis of the non-beta-lactamase-mediated resistance to beta-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada. Antimicrob Agents Chemother (1992) 1.55
In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae. Antimicrob Agents Chemother (1989) 1.49
Penicillin-binding proteins and bacterial resistance to beta-lactams. Antimicrob Agents Chemother (1993) 1.37
Molecular epidemiology of ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae. J Clin Microbiol (1998) 1.16
Rapid chemiluminescent nucleic acid assays for detection of TEM-1 beta-lactamase-mediated penicillin resistance in Neisseria gonorrhoeae and other bacteria. J Clin Microbiol (1988) 1.06
Modification in penicillin-binding proteins during in vivo development of genetic competence of Haemophilus influenzae is associated with a rapid change in the physiological state of cells. Infect Immun (1992) 0.96
Identification of a group of Haemophilus influenzae penicillin-binding proteins that may have complementary physiological roles. Antimicrob Agents Chemother (1990) 0.91
Molecular basis of the efficacy of cefaclor against Haemophilus influenzae. Antimicrob Agents Chemother (1992) 0.86
Mechanisms of resistance to cephalosporin antibiotics. Drugs (1987) 0.82
Effect of beta-lactams on peptidoglycan metabolism of Haemophilus influenzae grown in animals. Antimicrob Agents Chemother (1992) 0.77
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med (1998) 6.75
Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1984) 4.25
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA (1999) 3.53
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr (2000) 3.53
Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis (1996) 2.96
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis (2000) 2.90
Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing. Antimicrob Agents Chemother (1986) 2.38
Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3. Antimicrob Agents Chemother (1988) 2.28
Characterization of Haemophilus influenzae type b fimbriae. Infect Immun (1984) 2.00
Genetic and phenotypic diversity among ampicillin-resistant, non-beta-lactamase-producing, nontypeable Haemophilus influenzae isolates. Infect Immun (1987) 1.86
Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis (1985) 1.85
Problems with current recommendations for susceptibility testing of Haemophilus influenzae. Antimicrob Agents Chemother (1990) 1.84
A permeability barrier as a mechanism of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1985) 1.84
Bacteriology of acute otitis media: a new perspective. J Pediatr (1992) 1.80
Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine. A population-based case-control study. JAMA (1994) 1.71
Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatrics (2001) 1.70
Detection of relatively penicillin G-resistant Neisseria meningitidis by disk susceptibility testing. Antimicrob Agents Chemother (1987) 1.67
Incidence, adherence, and antibiotic resistance of coagulase-negative Staphylococcus species causing human disease. Diagn Microbiol Infect Dis (1984) 1.61
Comparison of conventional stool concentration and preserved-smear methods with Merifluor Cryptosporidium/Giardia Direct Immunofluorescence Assay and ProSpecT Giardia EZ Microplate Assay for detection of Giardia lamblia. J Clin Microbiol (1995) 1.61
Genetic diversity of penicillin G-resistant Neisseria meningitidis from Spain. Infect Immun (1989) 1.50
In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae. Antimicrob Agents Chemother (1989) 1.49
Electrodiagnosis reliability in the diagnosis of infant botulism. J Pediatr (1992) 1.41
Statistical comparison of ligand-binding kinetics. Stat Med (1989) 1.39
Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control. Vaccine (2000) 1.38
Plasmid-mediated resistance in multiply resistant Haemophilus influenzae type b causing meningitis: molecular characterization of one strain and review of the literature. J Infect Dis (1984) 1.32
In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains. Antimicrob Agents Chemother (1985) 1.31
Use of a high-sensitivity rapid strep test without culture confirmation of negative results: 2 years' experience. J Fam Pract (2000) 1.26
A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers. Vaccine (2000) 1.20
Postmarketing surveillance of oral terbinafine in the UK: report of a large cohort study. Br J Clin Pharmacol (1996) 1.20
Septic arthritis versus transient synovitis of the hip: the value of screening laboratory tests. Ann Emerg Med (1992) 1.20
Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial. J Clin Microbiol (2000) 1.10
Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J Pediatr (1996) 1.08
Cefuroxime treatment failure of nontypable Haemophilus influenzae meningitis associated with alteration of penicillin-binding proteins. J Infect Dis (1990) 1.08
Diagnostic usefulness of mycobacterial skin test antigens in childhood lymphadenitis. Pediatr Infect Dis J (1989) 1.08
NeuD plays a role in the synthesis of sialic acid in Escherichia coli K1. FEMS Microbiol Lett (2000) 1.06
Penicillin-binding proteins and ampicillin resistance in Haemophilus influenzae. J Antimicrob Chemother (1990) 1.05
Sensitive test for thyroid hormone autoantibodies in serum. Lancet (1982) 1.05
Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants. J Infect Dis (2001) 1.04
Cloning and expression in Escherichia coli of a gene encoding nonenzymatic chloramphenicol resistance from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1986) 1.01
Susceptibility to cephalosporins of penicillin-susceptible and penicillin-resistant strains of Neisseria gonorrhoeae from Philadelphia. Antimicrob Agents Chemother (1989) 0.94
Cyclospora species as a gastrointestinal pathogen in immunocompetent hosts. J Clin Microbiol (1995) 0.92
Clinical and microbiologic characteristics of cutaneous infection with Yersinia enterocolitica. J Infect Dis (1992) 0.92
The biologic activities of peptidoglycan in experimental Haemophilus influenzae meningitis. J Infect Dis (1993) 0.91
Rapid detection methods in microbiology: are they right for your office? Med Clin North Am (1987) 0.91
Half-life of human parainfluenza virus type 3 (hPIV3) maternal antibody and cumulative proportion of hPIV3 infection in young infants. J Infect Dis (2001) 0.90
Trimethoprim resistance in Haemophilus influenzae is due to altered dihydrofolate reductase(s). Biochem J (1991) 0.90
Molecular epidemiology of plasmid-mediated ampicillin resistance in Haemophilus influenzae type b isolates from Alaska. J Infect Dis (1985) 0.86
Mutation frequency of Haemophilus influenzae to rifampin resistance. Antimicrob Agents Chemother (1982) 0.85
Cerebrospinal fluid analysis in children with seizures. Pediatr Emerg Care (1995) 0.82
Filling the waiting time in the clinic with education about glaucoma. Insight (2001) 0.81
Safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine (PedvaxHIB) in Papua New Guinean children. P N G Med J (2000) 0.81
The in vitro antibacterial activity of ceftriaxone against Streptococcus pyogenes is unrelated to penicillin-binding protein 4. FEMS Microbiol Lett (1993) 0.81
Proteolytic activity of Candida albicans and other yeasts. Diagn Microbiol Infect Dis (1985) 0.80
IgG response to pneumococcal polysaccharide-protein conjugate appears similar to IgG response to polysaccharide in bone marrow transplant recipients and healthy adults. Clin Infect Dis (1997) 0.79
Effect of tobramycin on protein synthesis in 2-deoxystreptamine aminoglycoside-resistant clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother (1986) 0.79
Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children. Otitis Study Group. Pediatrics (1994) 0.79
Autoantibody production in Kawasaki syndrome. Clin Exp Rheumatol (1993) 0.78
Group A streptococcal infection and Kawasaki syndrome. Lancet (1991) 0.78
Acute-phase reactants and acute bacterial otitis media. Am J Dis Child (1992) 0.77
Virulence of non-beta-lactamase-mediated ampicillin-resistant Haemophilus influenzae. FEMS Microbiol Lett (1991) 0.76
PBP profiles of Haemophilus influenzae, H. aegyptius, and the H. influenzae biogroup aegyptius associated with Brazilian Purpuric Fever. Diagn Microbiol Infect Dis (1990) 0.76
Acute suppurative thyroiditis in pediatric patients. Pediatr Infect Dis J (1987) 0.75
Timing of the booster dose with Haemophilus polyribosylribitol phosphate conjugated with Neisseria outer-membrane protein. J Pediatr (1992) 0.75
Minitek urea disk test, a sensitive and cost-effective method to screen for Campylobacter pylori in gastric biopsies. J Clin Microbiol (1989) 0.75
Antimicrobial susceptibility of clinical isolates of Haemophilus influenzae to ampicillin-sulbactam. Diagn Microbiol Infect Dis (1991) 0.75
Analysis of the fecal microflora and its enzymatic activity in individuals genetically predisposed to colon cancer. Cancer Res (1982) 0.75
Pathogenesis of coronavirus SD in mice. I. Prominent demyelination in the absence of infectious virus production. Arch Neurol (1983) 0.75
Rapid methods in microbiology for in-office testing. Clin Lab Med (1986) 0.75
Lack of toxicity in two cases of neonatal acyclovir overdose. Pediatr Infect Dis J (1989) 0.75
Mumps meningoencephalitis. A possible clue to early diagnosis. Rocky Mt Med J (1975) 0.75
Ocular tuberculosis in a five-month-old. Pediatr Infect Dis J (1988) 0.75
The penicillin binding proteins of the genus Haemophilus. J Med Microbiol (1988) 0.75